SBIO vs. BNO
SBIO (ALPS Medical Breakthroughs ETF) and BNO (United States Brent Oil Fund LP) are both exchange-traded funds - SBIO is a Health & Biotech Equities fund tracking the S-Network Medical Breakthroughs Index, while BNO is a Oil & Gas fund tracking the Front Month Brent Crude Oil. Both are passively managed. Over the past 10 years, SBIO returned 8.03%/yr vs 13.13%/yr for BNO. At a 0.09 correlation, their price movements are largely independent. SBIO charges 0.50%/yr vs 0.90%/yr for BNO.
Performance
SBIO vs. BNO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SBIO achieves a 1.95% return, which is significantly lower than BNO's 85.31% return. Over the past 10 years, SBIO has underperformed BNO with an annualized return of 8.03%, while BNO has yielded a comparatively higher 13.13% annualized return.
SBIO
- 1D
- 2.35%
- 1M
- -5.55%
- YTD
- 1.95%
- 6M
- 4.13%
- 1Y
- 68.86%
- 3Y*
- 18.38%
- 5Y*
- 3.16%
- 10Y*
- 8.03%
BNO
- 1D
- -2.71%
- 1M
- -9.80%
- YTD
- 85.31%
- 6M
- 79.66%
- 1Y
- 88.71%
- 3Y*
- 26.74%
- 5Y*
- 23.48%
- 10Y*
- 13.13%
SBIO vs. BNO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SBIO ALPS Medical Breakthroughs ETF | 1.95% | 55.07% | 3.81% | 8.68% | -28.08% | -17.55% | 21.17% | 50.30% | -11.81% | 45.67% |
BNO United States Brent Oil Fund LP | 85.31% | -5.44% | 9.67% | -3.43% | 35.25% | 62.34% | -38.23% | 36.01% | -15.30% | 15.43% |
Correlation
The correlation between SBIO and BNO is -0.29, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.29 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.11 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.01 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2015 | 0.09 |
The correlation between SBIO and BNO shifts across timeframes, from -0.29 (1 year) to 0.09 (10 years), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SBIO vs. BNO — Risk / Return Rank
SBIO
BNO
SBIO vs. BNO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ALPS Medical Breakthroughs ETF (SBIO) and United States Brent Oil Fund LP (BNO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SBIO | BNO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.21 | ||
| Sortino ratioReturn per unit of downside risk | +0.57 | ||
| Omega ratioGain probability vs. loss probability | 1.38 | 1.36 | +0.01 |
| Calmar ratioReturn relative to maximum drawdown | 5.47 | 4.99 | +0.48 |
| Martin ratioReturn relative to average drawdown | 16.23 | 9.39 | +6.84 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| SBIO | BNO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.35 | 2.15 | +0.21 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.09 | 0.67 | -0.57 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.24 | 0.36 | -0.12 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.22 | 0.14 | +0.09 |
Drawdowns
SBIO vs. BNO - Drawdown Comparison
The maximum SBIO drawdown since its inception was -63.06%, smaller than the maximum BNO drawdown of -87.06%. Use the drawdown chart below to compare losses from any high point for SBIO and BNO.
Loading charts...
Drawdown Indicators
| SBIO | BNO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.06% | -87.06% | +24.00% |
Max Drawdown (1Y)Largest decline over 1 year | -12.66% | -17.87% | +5.21% |
Max Drawdown (3Y)Largest decline over 3 years | -42.44% | -23.75% | -18.69% |
Max Drawdown (5Y)Largest decline over 5 years | -53.10% | -33.70% | -19.40% |
Max Drawdown (10Y)Largest decline over 10 years | -63.06% | -75.18% | +12.12% |
Current DrawdownCurrent decline from peak | -14.84% | -12.72% | -2.12% |
Average DrawdownAverage peak-to-trough decline | -28.44% | -40.16% | +11.72% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.26% | 9.48% | -5.22% |
Volatility
SBIO vs. BNO - Volatility Comparison
The current volatility for ALPS Medical Breakthroughs ETF (SBIO) is 9.85%, while United States Brent Oil Fund LP (BNO) has a volatility of 14.12%. This indicates that SBIO experiences smaller price fluctuations and is considered to be less risky than BNO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SBIO | BNO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.85% | 14.12% | -4.27% |
Volatility (6M)Calculated over the trailing 6-month period | 22.76% | 36.21% | -13.45% |
Volatility (1Y)Calculated over the trailing 1-year period | 29.40% | 41.56% | -12.16% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.57% | 35.40% | -1.83% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.18% | 36.69% | -3.51% |
SBIO vs. BNO - Expense Ratio Comparison
SBIO has a 0.50% expense ratio, which is lower than BNO's 0.90% expense ratio.
Dividends
SBIO vs. BNO - Dividend Comparison
Neither SBIO nor BNO has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
BNO United States Brent Oil Fund LP | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SBIO ALPS Medical Breakthroughs ETF | 0.00% | 0.00% | 3.55% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% |
Frequently Asked Questions
SBIO and BNO have a correlation of -0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BNO has higher volatility (14.12%) compared to SBIO (9.85%). In terms of maximum drawdown, SBIO dropped -63.06% vs BNO's -87.06%.
On 10-year performance, BNO leads with 13.13% vs 8.03% for SBIO. On fees, SBIO is cheaper at 0.50% per year. On volatility, SBIO has been the lower-risk option at 9.85%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, BNO has performed better with a 13.13% return vs 8.03%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
SBIO is cheaper with a 0.50% expense ratio, compared with 0.90% for BNO.
SBIO and BNO have nearly identical dividend yields, around 0.00%.
SBIO is categorized as Health & Biotech Equities, while BNO is Oil & Gas. SBIO tracks S-Network Medical Breakthroughs Index, while BNO tracks Front Month Brent Crude Oil. They also come from different issuers: SS&C and Concierge Technologies. Their fees differ too: 0.50% for SBIO and 0.90% for BNO.
SBIO currently has the higher Sharpe Ratio (2.35 vs 2.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SBIO and BNO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer